PT-141, also known as bremelanotide in research literature, is a synthetic cyclic melanocortin peptide analogue. Laboratory literature discusses it in relation to central melanocortin receptor signalling, MC3R/MC4R pathway models, receptor-selective peptide activity, and neuroendocrine research systems.
The product is supplied for analytical and laboratory research contexts only. Description, categorisation, and customer-facing communication should avoid any therapeutic, body-use, veterinary, cosmetic, or outcome-focused language.
This product is supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. It is not intended for human or animal use.




